top border
top border
Featured Programs
Agent That Starves Tumor Cells May Improve Survival in Metastatic RCC
A novel glutaminase inhibitor CB-839, may provide a survival benefit in combination with cabozantinib (Cabometyx) by cutting off the energy supply to tumor cells in patients with metastatic renal cell carcinoma.
View Now
Treating Advanced Renal Cell Carcinoma
In this program moderated by Robert Figlin, MD, a panel of experts discusses modern day treatment of advanced kidney cancer. The discussants, Sandy Srinivas, MD; Nizar Tannir, MD, FACP; and Martin Voss, MD, focus on how to choose the right course of treatment for an individual patient.
View Now
Featured Video
Dr. Marshall on Physician Burnout in Oncology
John L. Marshall, MD, of Medstar Georgetown University Hospital, Otto J. Ruesch Center for the Cure of Gastrointestinal Cancer, Georgetown-Lombardi Comprehensive Cancer Center, discusses physician burnout in oncology. View now
Gina Columbus

Gina Columbus recaps some of the top news presented each day during the 2020 Genitourinary Cancers Symposium.

Publication Bottom Border
Border Publication
x